Under the terms of the agreement, Pfizer and Flagship will each contribute an upfront investment of $50 million. The collaboration will leverage Flagship’s rich ecosystem of biotechnology platforms and more than 40 human health companies.
Read More
Read More
Read More
After a small cancer drug study yielded the unprecedented result of 100 percent of participants entering remission, oncologists — and patients — wonder if the approach from the experimental drug trial can apply to other types of cancer.
The study out of Memorial Sloan Kettering Cancer Center in New York has oncologists excited over the prospect that immunotherapy, the treatment type used in the trial, has increasingly shown effectiveness — without surgery
Read More
GRAIL, a Silicon Valley startup, created the Galleri test, which can screen for more than 50 cancers by looking at blood for DNA shed by cancer tumors. If it sees that DNA, then it predicts where the cancer is. A positive result isn’t always accurate, but researchers at the National Cancer Institute say study results so far could potentially revolutionize cancer screening, and they’re designing bigger studies.
Read More
It was 50 years ago this month that Richard Nixon announced the War on Cancer, providing funding for research and cures. NBC News’ Harry Smith reports on how that battle has progressed, and what lies ahead.
Read More
Innovation Spotlight presentation at Amazon re:MARS, filmed on June 6, 2019 at ARIA Resort & Casino in Las Vegas, NV. Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management and director of the MIT Laboratory for Financial Engineering.
View Video